ALQA - Alliqua BioMedical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Alliqua BioMedical, Inc.

1010 Stony Hill Road
Suite 200
Yardley, PA 19067
United States
215-702-8550
http://www.alliqua.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees60

Key Executives

NameTitlePayExercisedYear Born
Mr. David Ian JohnsonCEO, Pres & Director606.4kN/A1958
Mr. Bradford C. BartonChief Operating Officer349.2kN/A1960
Mr. Pellegrino PionatiChief Strategy & Marketing Officer349.2kN/A1958
Dr. Phillip D. Forman M.D., DPMExec. VP of Clinical AffairsN/AN/A1959
Dr. Janice M. Smiell M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. The company markets MIST Ultrasound Healing Therapy, a painless noncontact low-frequency ultrasound to promote healing; and Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix, which are human biologic regenerative technologies. It also provides contract manufacturing services, including the development, manufacture, and marketing of high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Yardley, Pennsylvania.

Corporate Governance

Alliqua BioMedical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.